ANTI-ANGIOGENIC PEPTIDES DERIVED FROM HUMAN KININOGEN

Award Information

Agency: Department of Health and Human Services	Branch: N/A	Award ID: 45750	Program Year/Program: 1999 / SBIR
Agency Tracking Number: 1R43CA083536-01	Solicitation Year: N/A	Solicitation Topic Code: N/A	Solicitation Number: N/A

Small Business Information: ANGSTROM PHARMACEUTICALS, INC.
11585 SORRENTO VALLEY RD/STE 105 SAN DIEGO, CA 92121
View profile »

Woman-Owned: No

Minority-Owned: No

HUBZone-Owned: No

Phase 1: Fiscal Year: 1999

Title: ANTI-ANGIOGENIC PEPTIDES DERIVED FROM HUMAN KININOGEN

Agency: HHS

Contract: N/A

Award Amount: $100,017.00

Abstract:
Not Available Accurate Automation Corporation (AAC) and AMT USA proposes to develop a detailed survey and performance trade study of jet turbine engines currently available by the remotely controlled (RC) aircraft industry and perform preliminary ground testing on a baseline turbine engine. In addition, AAC proposes to perform conceptual design improvements and develop a test plan to validate un-installed and installed engine performance on the baseline engine. The proposed Phase I program includes a detailed analysis of current RC turbine engines, an engine ground test for performance evaluation and integration requirements, a conceptual engine design modification plan, and an advanced engine test plan designed to characterize the baseline engine performance. A second-generation turbine engine will be manufactured, ground tested, and perhaps even flight tested in Phase II on an AAC unmanned aerial vehicle (UAV).

Principal Investigator:
Andrew P. Mazar

Business Contact:

6193501760
JONES@ANGSTROMINC.COM

Small Business Information at Submission:

ANGSTROM PHARMACEUTICALS, INC.
11585 SORRENTO VALLEY RD/STE 105 SAN DIEGO, CA 92121

EIN/Tax ID: 330691094

DUNS: N/A

Number of Employees: N/A

Woman-Owned: No

Minority-Owned: No

HUBZone-Owned: No